Investment for health and wellbeing

Oriola's Interim Report Q3 2024 published - read the report here

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q3 2024 published

Improved profitability

Download Q3 report Download Q3 presentation Watch webcast recording

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

19.12.2024 | Stock exchange releases

Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek
11.12.2024 | Stock exchange releases

Oriola renews operating model and management team to accelerate strategy execution
30.10.2024 | Stock exchange releases

Oriola Corporation’s Interim Report January-September 2024
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts